Compare HURA & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HURA | SITC |
|---|---|---|
| Founded | 2009 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 154.8M |
| IPO Year | 2010 | 1994 |
| Metric | HURA | SITC |
|---|---|---|
| Price | $1.97 | $3.18 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.04 | N/A |
| AVG Volume (30 Days) | 202.8K | ★ 1.2M |
| Earning Date | 11-13-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 93.75% |
| EPS Growth | ★ 47.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $123,649,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.41 | $2.80 |
| 52 Week High | $3.43 | $8.95 |
| Indicator | HURA | SITC |
|---|---|---|
| Relative Strength Index (RSI) | 44.11 | 52.60 |
| Support Level | $1.96 | $2.86 |
| Resistance Level | $2.23 | $4.55 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 35.00 | 43.94 |
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing, and managing shopping centers.